You are here

News and Events

Research centre lobby

For an overview of the latest news, press releases and blog posts from Cancer Research UK visit the Cancer News page.

Below you will find the latest press releases, news and event information from the Cancer Research UK Commercial Partnerships team and our legal entity, Cancer Research Technology (CRT).

Date1	Press Release
19 April 2017	CRT Pioneer Fund, Cancer Research UK and NCI collaborate to boost research against the ‘undruggable’ RAS	Read more
28 February 2017	Hitgen and Cancer Research UK’s Manchester Institute enter licence agreement in lung cancer	Read more
7 February 2017	Cancer Research Technology, UCL, and Tusk Therapeutics join forces to develop cancer immunotherapies	Read more
20 January 2017	The CRT Pioneer Fund and Cancer Research UK’s Manchester Institute nominate cancer drug candidate	Read more
18 January 2017	MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunotherapies	Read more
15 December 2016	Cancer Research UK AND Bicycle Therapeutics have collaborated to trial new therapy for advanced solid tumours	Read more
8 December 2016	Cancer Research Technology Pioneer Fund announces investment in blood cancer drugs	Read more
4 November 2016	Cancer Research UK and Cancer Research Technology partner with TYG Oncology to develop next generation cancer vaccine	Read more
6 October 2016	CRT and University of Manchester receive success payment from GlaxoSmithKline for cancer epigenetics research collaboration	Read more
5 October 2016	Achilles Therapeutics launched with funds of £13.2 million to develop immunotherapies for cancer	Read more

Pages

Date	Other news
15 December 2011	FEATURE: Successful Discovery Committee grant application shows promise for novel drug combinations
15 December 2011	FEATURE: CCR4 - from target discovery to a license and sponsored collaboration with Affitech
15 December 2011	FEATURE: CRT reflects on a successful NCRI conference
1 September 2011	CRT's Discovery Laboratory Autotaxin programme progresses to Lead Optimisation
19 August 2011	Preclinical Development Candidate selected for Chk1 Inhibitor Programme
28 July 2011	FEATURE: Abiraterone receives approval from FDA to be marketed as a prostate cancer therapy - Zytiga
28 July 2011	FEATURE: BliNK Therapeutics, our 24th spin-out company is formed
28 July 2011	FEATURE: CRT pioneers new ways of generating exciting research and licensing discoveries
25 May 2011	New Type of Hormone Therapy Extends Prostate Cancer Patients' Lives, Study Finds
21 March 2011	Positive Results in Genentech Ph II Clinical Trial of GDC-0449 in Advanced Basal Cell Carcinoma

Pages